Amgen’s KRAS Inhibitor, MSD’s Cough Drug Sail through PAFSC, January Approval Likely

Amgen’s KRAS G12C inhibitor sotorasib and MSD’s cough medicine gefapixant were given the blessing for their approval from a key health ministry panel on December 2. If all goes well, they will be officially approved in January along with a...read more